CCM Pharmaceuticals Sdn Bhd & UPHA Pharmaceutical Manufacturing Sdn Bhd
  • Established in 1976
  • Located in Bangi, Selangor
  • Acquired by CCM Berhad in 1995 and became a wholly-owned subsidiary
  • Manufactures a wide range of Ethical and OTC products, mainly in OSD, liquids and cream forms
  • Operated by about 641 well-trained employees

Manufacturing Site 1


Bangi Site 1

  • Constructed in 1990
  • Manufacturing capacities include:
    - Tablets/ Capsules/ Granules/ Liquids
    - Topical/ Soft Gels
    - Penicillin (oral dosage)

Bangi Site 2

  • Constructed in 2008
  • State-of-the-art Intermediate Bulk Container (IBC) concept – 1 ton batch
  • Manufacturing capacities include:
    - Tablets (direct compression)
    - Capsules/ mini-tabs in capsules
Manufacturing Capacity for Bangi
Dosage Form Annual Capacity
Tablets (tabs) 2,000,000,000
Capsules (caps) 400,000,000
Soft Gels (units) 140,000,000
Creams & Ointments (kg) 108,000
Granules (1000kg) 180,000
Syrups (1000 litres) 1,800,000
Effervescent 107,000,000
Duopharma (M) Sdn Bhd
  • Founded in 1979 as a trading company in Klang
  • Manufactured Oral Solids in 1986
  • Started Haemodialysis & SVI products in 1996
  • Produced LVP – Irrigation solution in 1997
  • Produced the first dental cartridge in Malaysia in 2001
  • Listed on Bursa Malaysia in 2002
  • Commenced production of Sterile Cephalosporin powders in 2003
  • Acquired by and became a subsidiary of CCM Berhad in 2005
  • Operated by about 418 well-trained employees

Manufacturing Site 2


Klang 1

  • Constructed in 1995
  • Manufacturing capacities include:
    - Tablets/ Capsules
    - Liquids/ Liquid Capsules
    - Haemodialysis solutions
    - Irrigation Solutions

Klang 2

  • Constructed in 2000
  • Manufacturing capacities include:
    - Small volume injectables (SVIs)
    - Powder injectables (Cephalosporin)
    - Dental cartridges
    - Vaccines fill & finish
Manufacturing Capacity for Klang
Dosage Form Annual Capacity
SVI Ampoules and liquid vials 40,000,000
Sterile powder vials 5,000,000
SVI Cartridges 10,000,000
Eye drops (litres) 6,000
Haemo and Irrigation (litres) 8,000,000
Tablets (tabs) 1,000,000,000
Capsules (caps) 200,000,000
Granules (kg) 72,000
CCM Pharma Sdn Bhd
  • CCM Pharma acquired assets and brands of Malayan Pharmaceuticals Sdn Bhd in 2007
  • The plant located in Glenmarie was converted in one section into CCM’s R&D Centre, Innovax, and a segregated Cephalosporin facility at a different section to produce granules and capsules
  • Innovax is a specially designed in-house pharmaceutical R&D facility accredited with ISO/IEC 17025 standards with about 33 highly-trained technical specialists and support staff
  • The Cephalosporin plant was commissioned in Oct 2008 and commenced commercial production in April 2009
  • Today, the Cephalosporin plant has ceased manufacturing and renovated into Oncology plant targeted to complete in 2017

Manufacturing Site 3 and R&D Facility


Glenmarie Manufacturing

  • Under renovation to build HAPI Oncology plant
  • Current manufacturing capacities include non-sterile capsules & granules

Glenmarie R&D

  • Equipped with the latest laboratory technology including 6 HPLCs, 2 UPLCs and 4 dissolution testers
  • Houses lab scale equipment for formulation trials, designed towards GMP requirements